Current
$468B
5-Year Average
$303B
All-Time High
$468B
All-Time Low
$52.1B
Market cap daily chart for AbbVie (ABBV)
Aug 2, 2021 – Jul 29, 2026 · 1,253 trading days
Market Cap growth chart for AbbVie (ABBV) from 2017 to 2026
Latest: +15.4%
Market Cap history table for AbbVie (ABBV) from 2012 to 2026
| 2026 | $468B | +15.4% | +$62.2B | ||
| 2025 | $405B | +28.7% | +$90.3B | ||
| 2024 | $315B | +14.7% | +$40.3B | ||
| 2023 | $275B | -4.4% | -$12.6B | ||
| 2022 | $287B | +19.4% | +$46.7B | ||
| 2021 | $241B | +34.2% | +$61.3B | ||
| 2020 | $179B | +36.4% | +$47.9B | ||
| 2019 | $131B | -7.8% | -$11.1B | ||
| 2018 | $143B | -8.1% | -$12.5B | ||
| 2017 | $155B | +51.8% | +$52.9B | ||
| 2016 | $102B | +5.3% | +$5.16B | ||
| 2015 | $97B | -8.0% | -$8.38B | ||
| 2014 | $105B | +24.4% | +$20.7B | ||
| 2013 | $84.7B | +57.2% | +$30.8B | ||
| 2012 | $53.9B | — | — |
- 2026$468B+15.4%
- 2025$405B+28.7%
- 2024$315B+14.7%
- 2023$275B-4.4%
- 2022$287B+19.4%
- 2021$241B+34.2%
- 2020$179B+36.4%
- 2019$131B-7.8%
- 2018$143B-8.1%
- 2017$155B+51.8%
- 2016$102B+5.3%
- 2015$97B-8.0%
- 2014$105B+24.4%
- 2013$84.7B+57.2%
- 2012$53.9B—
Market Cap values are taken from AbbVie's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at AbbVie (ABBV)
According to AbbVie's latest reported financial statements, the company's latest reported market cap is $386B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2026's annual market cap for AbbVie (ABBV) came in at $468B – grew 15.4% year-over-year.
Looking at the 2021–2026 (5 years) stretch, AbbVie market cap compounded at +14.2% per year, sustaining 3 straight years of year-over-year growth.
Across the available history, market cap reached its high of $468B in 2026 and its low of $53.9B in 2012.
AbbVie Market Cap by Year
AbbVie Market Cap 2026: $468B
AbbVie market cap in 2026 was $468B, grew 15.4% from 2025. This figure represents the highest annual value in the available history.
AbbVie Market Cap 2025: $405B
2025's market cap for AbbVie came in at $405B, grew 28.7% from 2024.
AbbVie Market Cap 2024: $315B
AbbVie posted market cap of $315B in 2024, grew 14.7% from 2023.
AbbVie Market Cap 2023: $275B
In 2023, AbbVie reported market cap of $275B, edged down 4.4% below 2022.
AbbVie Market Cap 2022: $287B
AbbVie market cap in 2022 was $287B.
See more financial history for AbbVie (ABBV).
Sector peers by Market Cap
Healthcare peers of AbbVie (ABBV), ranked by their latest market cap
| $1.14T | |
| $640B | |
| $382B | |
| $322B | |
| $229B | |
| $214B | |
| $209B | |
| $188B |
- $1.14T
- $322B
- $229B
- $209B
Frequently asked questions
Test yourself on ABBV
Market Cap — 10 rounds, every one of them ABBV against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
AbbVie (ABBV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.